Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
Read More Clinical Trials, Amyotrophic Lateral Sclerosis, Drugs (Pharmaceuticals), Amylyx Pharmaceuticals Inc, Food and Drug Administration, Cohen, Joshua B, Klee, Justin, United States, your-feed-healthcare
